Xtalks Webinars

Accelerate launch alignment across medical and commercial teams with Laura Heyduk, Kirsten Duncan, PharmD and Brian O'Donnell in this webinar hosted by Amplity.

As launch environments grow more complex, leaner teams, tighter timelines, and increased payer scrutiny are making cross-functional collaboration essential. This session explores how early alignment across medical, commercial, market access, and compliance can improve decision-making, support compliant engagement, and strengthen launch readiness through shared insights and agile ex*****on.

Register for this webinar to learn how to align teams earlier, apply AI-driven insights more effectively, and build a more compliant, patient-centered launch strategy: https://buff.ly/xnYVX2m

Dive into the paper versus eCOA debate with Dawn Jordan, Paul O’Donohoe and Mark Wade in this webinar hosted by TransPerfect Life Sciences.

For many trial teams, modality decisions still reflect legacy assumptions rather than current evidence. This session offers a realistic assessment of where eCOA delivers stronger data quality, compliance oversight, and operational efficiency, and where paper remains a defensible fit for specific study designs and patient populations.

Register for this webinar to learn how eCOA can improve data quality, strengthen compliance monitoring, and support evidence-informed modality selection for modern trials: https://buff.ly/ljQiyPV

Redefine endpoint strategies under fast-moving oncology trial standards with Dr. Emiliano Calvo, Dr. Victor Moreno and Estelle Guiheneuf in this webinar hosted by TFS HealthScience.

Oncology protocols are being pressured by rapid shifts in endpoints, eligibility expectations, and regulatory thinking, leaving designs drafted even a year ago at risk of becoming outdated by readout. From ctDNA, MRD, and advanced imaging biomarkers to the evolving role of patient-reported outcomes, this session explores how sponsors can modernize protocol decisions without adding unnecessary complexity, site burden, or regulatory risk.

Register for this webinar to learn how oncology trial design has changed, where current protocols are most exposed, and how to make stronger endpoint and eligibility decisions for 2026: https://buff.ly/ctuPiwO

Navigate evolving single-use compliance demands with James Scull, PhD in this webinar hosted by BA Sciences.

As USP becomes official, biopharma teams can no longer rely on legacy indicators alone to justify single-use component suitability. This session explores how formal risk assessment and fit-for-purpose screening strategies can strengthen extractables and leachables evaluations, clarify testing expectations, and support more confident compliance decisions.

Register for this webinar to learn how to assess component risk, qualify screening methods, and interpret results with greater confidence: https://buff.ly/2WRLwHM

Accelerate trial readiness under mounting operational pressure with Craig McIlloney, Stephen Rayda and Jay Leonard in this webinar hosted by Worldwide Clinical Trials.

As study timelines tighten and resource demands grow more complex, digitally enabled FSP models are becoming a strategic advantage across clinical development. This session explores how technology can streamline workflows, improve cross-functional visibility, and support faster, better-informed decisions without compromising quality or operational control.

Register for this webinar to learn how digitally enabled FSP models can strengthen clinical development, accelerate decision-making, and apply emerging technologies more effectively in real-world partnerships: https://buff.ly/G3UYkB7

Transform labeling risk and launch pressure with Jackie Leslie, Samantha Thompson and Chris Janczar in this webinar hosted by Esko.

As regulatory complexity rises, life sciences teams can no longer depend on late-stage checks to catch artwork and labeling errors. This session explores how AI and automation embed quality earlier in the workflow, reduce rework, strengthen compliance, and connect cross-functional teams with greater speed and control.

Register for this webinar to learn how AI-driven quality checks, agentic automation, and connected data can reduce recall risk and accelerate delivery with confidence: https://buff.ly/KS4hWHD

Transform fragmented pharma engagement with Eunice Youhanna, Dr. Johannes Boshkow and Srihari Sarangan in this webinar hosted by Microsoft.

Pharma commercial teams are under pressure to deliver more relevant, coordinated engagement while navigating fragmented data, tighter regulatory expectations, and growing demands for measurable impact. This session explores how AI-enabled commercial models can connect medical, marketing, and sales around shared insights, stronger governance, and more consistent ex*****on across channels.

Register for this webinar to learn how AI supports compliant, data-driven decisions and connected commercial models built on trust and operational alignment: https://buff.ly/LUsy3vz